Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Aspira Women's Health Inc. issued up to 4,455,000 shares of common stock of warrant to accredited and institutional investors.
- Security
- warrant
- Shares
- up to 4,455,000 shares of common stock
- Purchaser
- accredited and institutional investors
Exact text from the filing
warrants (the “Common Warrants”) to purchase up to 4,455,000 shares of the Company’s Common Stock, at a purchase price of $0.45 per share of Common Stock and accompanying warrants.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Aspira Women's Health Inc. issued 3,300,000 shares of common stock to accredited and institutional investors for $0.45 per share.
- Security
- common stock
- Shares
- 3,300,000 shares
- Purchaser
- accredited and institutional investors
- Consideration
- $0.45 per share
Exact text from the filing
for the issuance and sale in a private placement (the “Private Placement”) of (i) 3,300,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 (the “Common Stock”) and (ii) warrants (the “Common Warrants”) to purchase up to 4,455,000 shares of the Company’s Common Stock, at a purchase price of $0.45 per share of Common Stock and accompanying warrants.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Aspira Women's Health Inc. entered into Purchase Agreement with accredited and institutional investors valued at approximately $1.485 million (effective 2026-06-05).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- accredited and institutional investors
- Value
- approximately $1.485 million
- Effective
- 2026-06-05
Exact text from the filing
On June 5, 2026, Aspira Women’s Healthcare Inc. (the “Company”) entered into securities purchase agreements (the “Purchase Agreement”) with accredited and institutional investors (“the “Purchasers”) for the issuance and sale in a private placement (the “Private Placement”) of (i) 3,300,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 (the “Common Stock”) and (ii) warrants (the “Common Warrants”) to purchase up to 4,455,000 shares of the Company’s Common Stock, at a purchase price of $0.45 per share of Common Stock and accompanying warrants.
View on SEC.gov